The delivery of nano-formulated drugs to solid tumours is selectively increased by co-application of the vascular disrupting agent CA4P

Authors:
Preprint
Publisher website
Google Scholar
Abstract
Improving the efficacy of existing cytotoxic chemotherapeutics requires increasing drug delivery to tumours while minimising systemic toxicity. Formulating these drugs as nanoparticles can reduce their exposure to healthy tissues, but broadly applicable strategies to enhance tumoral accumulation are lacking. Here, we show that co-administering small molecule vascular disrupting agents together with nanoparticle formulations (e.g. diagnostic reporters, or clinical drugs irinotecan and doxorubicin) increases their tumoral uptake by up to threefold, without raising systemic exposure. In a syngeneic mouse model of triple-negative breast cancer, this enhancement diminished when co-treatments were repeated, limiting its therapeutic benefit. However, since most solid tumour types are susceptible to vascular disrupting agents, this approach may be a broadly applicable strategy to improve the selectivity of drug delivery: with particular relevance for single dose use in diagnostic or research settings. Graphical
All Related Versions
Funding Information
  • German Federal Ministry of Education and Research (031B0159)
  • German Federal Ministry of Education and Research (031B0396)
  • German Federal Ministry of Education and Research (031B0632)
  • German Federal Ministry of Education and Research (161B0632)
  • France Life Imaging (ANR-11-INBS-0006)
  • Infrastructures de recherche en biologie, santé et agronomie, France

This publication has 22 references indexed in Scilit: